Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 24, 2014 18:00 ET | Source: Nanosphere, Inc.

Verigene(R) Enteric Pathogens Test Receives FDA Clearance

NORTHBROOK, Ill., June 24, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing the practice of medicine through targeted molecular diagnostics, today announced it has received...
June 23, 2014 08:00 ET | Source: Nanosphere, Inc.

Nanosphere Signs Molecular Diagnostic Supply Agreement With HealthTrust

NORTHBROOK, Ill., June 23, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that it has been selected by...
May 21, 2014 08:00 ET | Source: Nanosphere, Inc.

Twelve Studies Presented at ASM 2014 Highlight New Performance and Clinical Outcome Data Using Select Verigene Infectious Disease Tests

NORTHBROOK, Ill., May 21, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that twelve studies evaluating...
May 16, 2014 08:00 ET | Source: Nanosphere, Inc.

New Performance and Clinical Outcome Data from Twelve Studies Using Nanosphere's Infectious Disease Tests to be Presented at ASM 2014

NORTHBROOK, Ill., May 16, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that new performance and...
May 14, 2014 08:00 ET | Source: Nanosphere, Inc.

Studies Presented at ECCMID 2014 Highlight Accuracy and Potential Clinical Utility of Several Nanosphere Infectious Disease Tests

NORTHBROOK, Ill., May 14, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that six studies performed by...
May 08, 2014 08:00 ET | Source: Nanosphere, Inc.

New Validation and Clinical Outcome Data From Several Studies Using Nanosphere's Infectious Disease Tests to be Presented at ECCMID 2014

NORTHBROOK, Ill., May 8, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that new validation and clinical...
May 07, 2014 08:00 ET | Source: Nanosphere, Inc.

Nanosphere Announces First Quarter Financial and Operating Results

Corporate Highlights and Business Guidance: Achieved 48 new Verigene® customer placements Achieved Q1 2014 revenues of $3.3 million, a 39% increase over Q1 2013 Reaffirmed 2014...
April 17, 2014 08:00 ET | Source: Nanosphere, Inc.

Nanosphere to Release First Quarter Results and Host Investor Conference Call on Wednesday, May 7, 2014

NORTHBROOK, Ill., April 17, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that it will report its...
April 04, 2014 18:30 ET | Source: Nanosphere, Inc.

Nanosphere Clarifies Recent Transactions in Company's Common Stock

NORTHBROOK, Ill., April 4, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH) today clarified recent transactions in Nanosphere's common stock by certain of its directors and significant...
April 03, 2014 17:00 ET | Source: Nanosphere, Inc.

Nanosphere to Present at the 13th Annual Needham Healthcare Conference

NORTHBROOK, Ill., April 3, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that that an overview of the...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right